Cystic fibrosis and travel insurance  by Tan, H.G. et al.
S108 10. Nursing and Psychosocial Issues
418 Consultation-liaison services for children and adolescents with
cystic ﬁbrosis
A. Gritti1, S. Chiapparo1, A. Sepe2, F. De Gregorio2, V. Fiorito2, F. Maio2,
V. Raia2,3. 1Second University of Naples, Department of Child Neuropsychiatry,
Naples, Italy; 2University ‘Federico II’, Department of Pediatrics, Naples, Italy;
3Regional Children and Adolescents CF Unit, Naples, Italy
Objectives: Liaison child psychiatry (LCP) provides integrated medical and psycho-
logical care for children and adolescents, affected by chronic disease, through col-
laboration between child psychiatrists, paediatricians and other specialities (Black,
1994). Psychiatric and psychological problems have an increased frequency in
subjects with cystic ﬁbrosis (CF), for which LCP activities are particularly useful
(Gritti A., Chiapparo S. et al., 2003). In this study we aim to describe our LCP
experiences with CF children and adolescents.
Methods: Until now our LCP services has assessed 87 SS (M 50.3%, F 49.7%),
divided for these age groups: 15.7% between 1 month−4 years; 45.2% between
5−14 years; 12.2% between 15−18 years; 2.6% >18 years.
Results: Requests for consultation fall into following categories: behaviour/conduct
disorders (22.4%); reactions to clinic treatment (17.8%); learning difﬁculties
(19.3%); depression (11.2%); eating disorders (8.1%); anxiety (7.1%); tic and stut-
tering (3.0%); psychological preparation for transplant surgery (3.0%). Diagnosis
of psychopathological disorder (or psychopathological risk) was made for 24.7%
of subjects, for them psychotherapy was prescribed. While in 72% of subjects, the
symptoms resulted correlated to momentary state of psychological crisis, for which
a programme of counselling was organized.
Conclusion: Our experiences conﬁrm that LCP services have a central role in the
management of CF subjects. In according to our studies, one of the tasks of LCP
is to realize psychological assessment, in order to early detection of subjects with
developmental risk, for them we must design speciﬁc psychological treatment.
419 The role of pets in the lives of adult cystic ﬁbrosis patients
F. Dowdall1, J. Fitzjohn1. 1Wythenshawe Hospital, The Manchester Adult Cystic
Fibrosis Centre, Manchester, United Kingdom
Background: Social workers in the Manchester CF Centre support and advise over
300 patients and were aware of the importance and difﬁculties of pet ownership.
Aim: To explore patients’ views regarding the role of pets in their lives and use
this information to determine whether better information and resources could help
alleviate patient anxieties regarding their pets during periods of hospitalisation.
Method: Questionnaires (Q’s) were sent to all patients. As well as demographic
questions, qualitative data was analysed thematically under the following headings;
the advantages and disadvantages of having a pet, and issues associated with
hospitalisation including an anxiety score from 1−10 (1 = low).
Results: Of 327 Q’s sent out 104 (32%) were returned. Of these 51 patients (49%)
owned pets. Frequently mentioned advantages: motivation to exercise, company
and mutual & unconditional love. Disadvantages: ﬁnding a carer when away or
in hospital, the need for increased cleaning and difﬁculty with exercising pet/s
when patient is unwell. Anxiety regarding hospitalisation: 60% scored 2 or less
and 20% scored 8 or more. Of those scoring high anxiety, the main concerns were
emotions associated with separation, anxieties about the pet being alone and ﬁnding
pet carers. Those with low anxiety scores were rarely or never in hospital or had
sufﬁcient help from others.
Conclusion: Pets are clearly important in maximising the physical and emotional
life of their owners and in particular, the emotional support offered by pets is
valued by all patients. The social workers intend to provide information regarding
animal shelters and charities and to explore how patients can access their pets whilst
inpatients.
420 Lung function, employment and beneﬁts in an adult CF population
D. Nazareth1, H. Tan1, A. Abdul1, T. Jordan1, J. Greenwood1, M. Ledson1,
M. Walshaw1. 1Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
Despite the improving prognosis in CF, many UK patients have previously been
encouraged to apply for Social Service Beneﬁts, including the Disability Living
Allowance (DLA). The UK Government is closely scrutinising beneﬁt claimants:
we therefore interviewed a random sample of 37 CF patients (mean age 26 years
[range 17 to 48], 18 male) attending our adult centre using a structured questionnaire
to look at employment history, housing, motoring and the beneﬁts received. We
correlated this with spirometry (a marker of disease severity).
As regards occupation, 11 were employed part time (average 25 hours per week)
and 9 students: 12 had previously been employed; 8 quitting for health reasons.
As regards housing, 16 lived with parents, 6 in social housing, 7 rented, and the
remainder had mortgages. 32 (86%) owned a car: 16 (50%) provided through Mota-
bility beneﬁt. Overall, 35 (95%, 17 males) received some beneﬁt, including 24 high
level and 8 middle level DLA. A further 11 took up additional beneﬁts (9 incapacity
beneﬁt, 1 child tax credit, 1 job seekers allowance). There were correlations between
severity of lung disease, and the beneﬁts received and unemployment, but these were
not strong (r = 0.53, p< 0.01 and r = 0.38, p< 0.02) respectively.
Although most of our CF patients receive beneﬁts, there was no clear relationship
with the degree of disability. Given the close scrutiny many existing claimants are
undergoing by the State in the UK, it may be more appropriate to encourage adult
CF individuals to lead independent lives and obtain employment, indicating the
improving outlook for this group of patients with a chronic illness.
421 Cystic ﬁbrosis and travel insurance
H.G. Tan1, D. Nazareth1, A. Abdul1, T. Jordan1, J. Greenwood1, M. Ledson1,
M. Walshaw1. 1Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
Obtaining travel insurance can be difﬁcult for people with cystic ﬁbrosis (CF),
where there are an increasing number of young adults who are keen to travel. We
randomly interviewed 24 patients (mean age 25 years [range 17 to 48], mean FEV1
67% predicted [range 23 to 135], 16 female) attending our adult CF clinic using a
standardised questionnaire, to look at travel history, information supplied, and the
cost and availability of resulting quotes.
Only 18 (75%) obtained travel insurance (12 via the internet), and only 8 (44%)
declared their CF. Mean insurance cost (CF declared) was £246.80 (range 120
to 400), compared to £31.20 (range 5 to 100) excluding CF cover. Two patients
were refused cover when they declared their CF. Uninsured patients and those with
CF excluded from cover perceived the inclusive cost to be too expensive: 5 had
previously received quotes from £600 to £3500 (all in excess of the total holiday
cost). Quotes did not allow for the degree of CF disease: 2 patients (FEV1%
predicted values of 72 and 100) paid £400 each for a week of transatlantic holiday
whilst another (FEV1 59% predicted) only paid £150.
The CF diagnosis has a signiﬁcant impact on travel insurance cost, independent
of the degree of CF disease and therefore the associated travel risk. Many patients
either do not declare their CF condition (invalidating their insurance) or travel
uninsured, courting the risk of expensive uninsured healthcare needs in foreign
countries. There is a need for specialised travel insurance for patients with chronic
diseases (including CF), which takes into account the degree of illness and thereby
the risk associated with travel.
